Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract.

[1]  C. Rouzioux,et al.  Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine. , 2008, The Journal of antimicrobial chemotherapy.

[2]  P. Roques,et al.  Infection of Semen-Producing Organs by SIV during the Acute and Chronic Stages of the Disease , 2008, PloS one.

[3]  S. Kalichman,et al.  Human Immunodeficiency Virus Viral Load in Blood Plasma and Semen: Review and Implications of Empirical Findings , 2008, Sexually transmitted diseases.

[4]  J. Ray,et al.  Quantification of antiretroviral drugs for HIV‐1 in the male genital tract: current data, limitations and implications for laboratory analysis , 2007, The Journal of pharmacy and pharmacology.

[5]  V. Soriano,et al.  Is natural conception a valid option for HIV-serodiscordant couples? , 2007, Human reproduction.

[6]  Christophe Pasquier,et al.  Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies , 2007, Journal of Clinical Microbiology.

[7]  A. Wensing,et al.  No Virological Failure in Semen During Properly Suppressive Antiretroviral Therapy Despite Subtherapeutic Local Drug Concentrations , 2006, HIV clinical trials.

[8]  A. Collier,et al.  Lower Genitourinary Tract Sources of Seminal HIV , 2006, Journal of acquired immune deficiency syndromes.

[9]  J. Mellors,et al.  Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy. , 2004, AIDS research and human retroviruses.

[10]  C. Katlama,et al.  Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men , 2004, AIDS.

[11]  P. Cane,et al.  Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen. , 2004, The Journal of antimicrobial chemotherapy.

[12]  A. Antinori,et al.  Differences between semen and plasma of nucleoside reverse transcriptase resistance mutations in HIV-infected patients, using a rapid assay. , 2004, In vivo.

[13]  A. Berrebi,et al.  Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes , 2004, AIDS.

[14]  Roland Tubiana,et al.  Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men , 2004, AIDS.

[15]  C. Rouzioux,et al.  Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012). , 2002, AIDS.

[16]  C. Solas,et al.  Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: Clinical correlations , 2002, HIV clinical trials.

[17]  D. Pillay,et al.  The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis , 2002, AIDS.

[18]  A. Kiessling,et al.  Multiple drug resistance mutations in human immunodeficiency virus in semen but not blood of a man on antiretroviral therapy. , 2000, Urology.

[19]  Hui Zhang,et al.  Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. , 1998, The New England journal of medicine.